Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors.
Mahmoud HamedMahmoud El-HasabFotouh Rashed MansourPublished in: Virusdisease (2021)
The online version contains supplementary material available at 10.1007/s13337-021-00691-6.